Inventor · disambiguated record
James West
Also filed as: WEST JAMES · WEST JAMES W · WEST JAMES WILLAM
35 granted patents·48 pending applications·388 citations·filing 1995–2025
97Inventor score
Files withZYMOGENETICS INC30CUMBERLAND PHARMACEUTICALS INC21MICE WITH HORNS LLC9AGGENETICS INC5WEST JAMES W5
Top patents by PatentIndex Score
83 records- 0196US9695238B2Screening method for inhibitors of binding of zBR7R1 to CD155ZYMOGENETICS INC·Filed 2016·Granted Jul 4, 2017·22 cites·14 claims
- 0296US7790862B2IL-17 and IL-23 antagonists and methods of using the sameZYMOGENETICS INC·Filed 2007·Granted Sep 7, 2010·49 cites·14 claims
- 0396US6814965B2Methods of decreasing ZVEGF3 activityZYMOGENETICS INC·Filed 2002·Granted Nov 9, 2004·44 cites·8 claims
- 0495US9994637B2Method of treating CD155 expressing cancersZYMOGENETICS INC·Filed 2017·Granted Jun 12, 2018·11 cites·10 claims
- 0594US7186805B2IL-21 antagonistsZYMOGENETICS INC·Filed 2005·Granted Mar 6, 2007·21 cites·2 claims
- 0694US6929932B2IL-21 antagonistsZYMOGENETICS INC·Filed 2002·Granted Aug 16, 2005·51 cites·5 claims
- 0794US6777539B2Soluble zalpha11 cytokine receptorsZYMOGENETICS INC·Filed 2001·Granted Aug 17, 2004·45 cites·28 claims
- 0891US6528050B1Growth factor homolog zvegf3ZYMOGENETICS INC·Filed 2000·Granted Mar 4, 2003·16 cites·15 claims
- 0991US6432673B1Growth factor homolog ZVEGF3ZYMOGENETICS INC·Filed 1999·Granted Aug 13, 2002·38 cites·26 claims
- 1089US7629452B2Polynucleotides encoding soluble zalpha11 cytokine receptorsZYMOGENETICS INC·Filed 2006·Granted Dec 8, 2009·8 cites·15 claims
- 1188US7445772B2Heterodimeric four helix bundle cytokinesZYMOGENETICS INC·Filed 2007·Granted Nov 4, 2008·9 cites·2 claims
- 1288US2025114334A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1387US7410780B2IL-21 antagonistsZYMOGENETICS INC·Filed 2006·Granted Aug 12, 2008·7 cites·3 claims
- 1485US9693998B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·4 cites·20 claims
- 1584US6531576B1Four-helical bundle protein zsig81ZYMOGENETICS INC·Filed 2000·Granted Mar 11, 2003·8 cites·9 claims
- 1684US2023381147A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1783US8227579B2IL-23 antagonistsLEWIS KATHERINE E·Filed 2010·Granted Jul 24, 2012·8 cites·5 claims
- 1883US7470665B2Methods for targeting cells that express fibroblast growth receptor-3 or -2ZYMOGENETICS INC·Filed 2003·Granted Dec 30, 2008·7 cites·17 claims
- 1980US7189695B2Soluble zalpha11 cytokine receptorsZYMOGENETICS INC·Filed 2004·Granted Mar 13, 2007·8 cites·8 claims
- 2080US2022002419A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2021·Application pending·0 cites
- 2179US2025297010A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2025·Application pending·0 cites
- 2278US12161632B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·0 cites·10 claims
- 2378US10716298B2Materials and methods for producing animals with short hairACCELIGEN INC·Filed 2015·Granted Jul 21, 2020·2 cites·5 claims
- 2478US10314824B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·1 cites·9 claims
- 2578US10064845B2Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Sep 4, 2018·2 cites·22 claims
- 2677US7763713B2Zalpha11 cytokine receptorsZYMOGENETICS INC·Filed 2006·Granted Jul 27, 2010·1 cites·11 claims
- 2777US2022133696A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2876US2025049764A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2975US7196172B2Heterodimeric four helix bundle cytokinesZYMOGENETICS INC·Filed 2006·Granted Mar 27, 2007·2 cites·19 claims
- 3073US2021137895A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3172US10925860B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Feb 23, 2021·0 cites·7 claims
- 3272US2025368711A1Compositions and methods for treating meibomian gland dysfunctionCAVALRY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3372US2019375843A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2019·Application pending·0 cites
- 3471US2021015798A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3570US2010074905A1Methods for soluble zalpha11 cytokine receptorsZYMOGENETICS INC·Filed 2009·Application pending·0 cites
- 3670US2020253935A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3769US10583126B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Mar 10, 2020·0 cites·7 claims
- 3869US7387885B2Growth factor homolog zvegf3 polynucleotidesZYMOGENETICS INC·Filed 2004·Granted Jun 17, 2008·0 cites·6 claims
- 3969US2025376500A1Compositions and methods for treating meibomian gland dysfunctionCAVALRY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 4069US2018251556A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2018·Application pending·0 cites
- 4168US2020113872A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4268US2009156495A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2008·Application pending·0 cites
- 4367US2015152160A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2014·Application pending·0 cites
- 4467US2019343809A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4565US8052976B2Growth factor homolog ZVEGF3ZYMOGENETICS INC·Filed 2008·Granted Nov 8, 2011·0 cites·3 claims
- 4665US2019117628A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4764US10016399B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Jul 10, 2018·0 cites·19 claims
- 4863US10456380B2Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Oct 29, 2019·0 cites·20 claims
- 4963US2019300901A1Materials and methods for making a recessive gene dominantAGGENETICS INC·Filed 2019·Application pending·0 cites
- 5062US9670458B2Methods for spermatogonial stem cell (SSC) transferMICE WITH HORNS LLC·Filed 2014·Granted Jun 6, 2017·1 cites·25 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James West files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →